REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
STRW vs SBRA vs CTRE vs LTC vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
STRW vs SBRA vs CTRE vs LTC vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $170M | $5.19B | $8.82B | $1.91B | $94M |
| Revenue (TTM) | $145M | $813M | $468M | $309M | $148M |
| Net Income (TTM) | $7M | $156M | $335M | $121M | $2M |
| Gross Margin | 81.4% | 63.5% | 86.8% | 79.6% | 68.8% |
| Operating Margin | 54.3% | 29.0% | 69.1% | 53.9% | 24.9% |
| Forward P/E | 19.4x | 29.8x | 26.6x | 19.9x | 595.7x |
| Total Debt | $672M | $2.55B | $894M | $845M | $654M |
| Cash & Equiv. | $48M | $72M | $198M | $14M | $7M |
STRW vs SBRA vs CTRE vs LTC vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Strawberry Fields R… (STRW) | 100 | 125.7 | +25.7% |
| Sabra Health Care R… (SBRA) | 100 | 156.9 | +56.9% |
| CareTrust REIT, Inc. (CTRE) | 100 | 218.2 | +118.2% |
| LTC Properties, Inc. (LTC) | 100 | 103.2 | +3.2% |
| Global Medical REIT… (GMRE) | 100 | 81.3 | -18.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STRW vs SBRA vs CTRE vs LTC vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STRW is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (19.4x vs 595.7x)
SBRA lags the leaders in this set but could rank higher in a more targeted comparison.
CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- 265.1% 10Y total return vs SBRA's 50.9%
- Lower volatility, beta 0.14, Low D/E 22.1%, current ratio 1.54x
- PEG 1.25 vs LTC's 24.47
Among these 5 stocks, LTC doesn't own a clear edge in any measured category.
GMRE ranks third and is worth considering specifically for income & stability.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 63.5% yield, 5-year raise streak, vs CTRE's 3.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.8% FFO/revenue growth vs GMRE's -1.8% | |
| Value | Lower P/E (19.4x vs 595.7x) | |
| Quality / Margins | 71.5% margin vs GMRE's 1.7% | |
| Stability / Safety | Beta 0.14 vs STRW's 0.69, lower leverage | |
| Dividends | 63.5% yield, 5-year raise streak, vs CTRE's 3.2% | |
| Momentum (1Y) | +40.3% vs GMRE's +0.1% | |
| Efficiency (ROA) | 6.7% ROA vs GMRE's 0.2%, ROIC 6.1% vs 2.0% |
STRW vs SBRA vs CTRE vs LTC vs GMRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
STRW vs SBRA vs CTRE vs LTC vs GMRE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTRE leads in 2 of 6 categories
STRW leads 2 • SBRA leads 1 • GMRE leads 1 • LTC leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBRA is the larger business by revenue, generating $813M annually — 5.6x STRW's $145M. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $145M | $813M | $468M | $309M | $148M |
| EBITDAEarnings before interest/tax | $123M | $432M | $428M | $207M | $95M |
| Net IncomeAfter-tax profit | $7M | $156M | $335M | $121M | $2M |
| Free Cash FlowCash after capex | $88M | $367M | $400M | $137M | $19M |
| Gross MarginGross profit ÷ Revenue | +81.4% | +63.5% | +86.8% | +79.6% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +54.3% | +29.0% | +69.1% | +53.9% | +24.9% |
| Net MarginNet income ÷ Revenue | +4.8% | +19.2% | +71.5% | +39.1% | +1.7% |
| FCF MarginFCF ÷ Revenue | +60.7% | +45.1% | +85.5% | +44.4% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +34.8% | +20.8% | +99.3% | +94.6% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.7% | -5.9% | +2.9% | +6.7% | -166.2% |
Valuation Metrics
STRW leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 15.3x trailing earnings, LTC trades at a 87% valuation discount to GMRE's 115.3x P/E. Adjusting for growth (PEG ratio), CTRE offers better value at 1.19x vs LTC's 24.47x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $170M | $5.2B | $8.8B | $1.9B | $94M |
| Enterprise ValueMkt cap + debt − cash | $793M | $7.7B | $9.5B | $2.7B | $741M |
| Trailing P/EPrice ÷ TTM EPS | 22.72x | 32.16x | 25.17x | 15.33x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.44x | 29.83x | 26.58x | 19.90x | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.19x | 24.47x | — |
| EV / EBITDAEnterprise value multiple | 8.31x | 17.01x | 23.03x | 16.67x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 1.45x | 6.70x | 18.51x | 7.28x | 0.68x |
| Price / BookPrice ÷ Book value/share | 1.10x | 1.78x | 2.00x | 1.55x | 0.17x |
| Price / FCFMarket cap ÷ FCF | 4.81x | 14.89x | 23.27x | 14.07x | — |
Profitability & Efficiency
STRW leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
STRW delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $0 for GMRE. CTRE carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to STRW's 8.04x. On the Piotroski fundamental quality scale (0–9), STRW scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.2% | +5.6% | +8.6% | +10.9% | +0.5% |
| ROA (TTM)Return on assets | +0.8% | +2.8% | +6.7% | +6.0% | +0.2% |
| ROICReturn on invested capital | +7.2% | +3.8% | +6.1% | +5.1% | +2.0% |
| ROCEReturn on capital employed | +9.0% | +5.2% | +7.7% | +7.0% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | 8.04x | 0.90x | 0.22x | 0.73x | 1.18x |
| Net DebtTotal debt minus cash | $623M | $2.5B | $696M | $830M | $647M |
| Cash & Equiv.Liquid assets | $48M | $72M | $198M | $14M | $7M |
| Total DebtShort + long-term debt | $672M | $2.6B | $894M | $845M | $654M |
| Interest CoverageEBIT ÷ Interest expense | 1.82x | 2.40x | 8.44x | 4.51x | 1.14x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $19,660 today (with dividends reinvested), compared to $7,855 for GMRE. Over the past 12 months, CTRE leads with a +40.3% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors CTRE at 29.6% vs GMRE's 1.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.0% | +9.0% | +9.9% | +13.7% | +6.9% |
| 1-Year ReturnPast 12 months | +29.7% | +20.5% | +40.3% | +12.9% | +0.1% |
| 3-Year ReturnCumulative with dividends | +109.3% | +113.0% | +117.8% | +35.5% | +5.6% |
| 5-Year ReturnCumulative with dividends | +47.8% | +49.9% | +96.6% | +22.3% | -21.4% |
| 10-Year ReturnCumulative with dividends | +47.8% | +50.9% | +265.1% | +26.9% | +308.1% |
| CAGR (3Y)Annualised 3-year return | +27.9% | +28.7% | +29.6% | +10.7% | +1.8% |
Risk & Volatility
SBRA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SBRA is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than STRW's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.7% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | -0.06x | 0.14x | -0.02x | 0.48x |
| 52-Week HighHighest price in past year | $14.00 | $21.07 | $41.72 | $40.80 | $39.93 |
| 52-Week LowLowest price in past year | $9.46 | $17.08 | $27.72 | $33.64 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +92.5% | +97.7% | +94.7% | +94.7% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 51.6 | 54.5 | 54.5 | 50.0 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 23K | 2.1M | 2.5M | 347K | 130K |
Analyst Outlook
GMRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: STRW as "Buy", SBRA as "Hold", CTRE as "Buy", LTC as "Hold", GMRE as "Buy". Consensus price targets imply 18.4% upside for STRW (target: $15) vs -6.8% for LTC (target: $36). For income investors, GMRE offers the higher dividend yield at 63.51% vs CTRE's 3.22%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $15.33 | $21.20 | $42.50 | $36.00 | $40.00 |
| # AnalystsCovering analysts | 2 | 29 | 19 | 22 | 22 |
| Dividend YieldAnnual dividend ÷ price | +4.4% | +5.8% | +3.2% | +6.0% | +63.5% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 2 | 1 | 5 |
| Dividend / ShareAnnual DPS | $0.57 | $1.18 | $1.27 | $2.31 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% | +0.0% | +0.3% | 0.0% |
CTRE leads in 2 of 6 categories (Income & Cash Flow, Total Returns). STRW leads in 2 (Valuation Metrics, Profitability & Efficiency).
STRW vs SBRA vs CTRE vs LTC vs GMRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is STRW or SBRA or CTRE or LTC or GMRE a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). LTC Properties, Inc. (LTC) offers the better valuation at 15. 3x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate Strawberry Fields REIT LLC (STRW) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — STRW or SBRA or CTRE or LTC or GMRE?
On trailing P/E, LTC Properties, Inc.
(LTC) is the cheapest at 15. 3x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, Strawberry Fields REIT LLC is actually cheaper at 19. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CareTrust REIT, Inc. wins at 1. 25x versus LTC Properties, Inc. 's 24. 47x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — STRW or SBRA or CTRE or LTC or GMRE?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +96. 6%, compared to -21. 4% for Global Medical REIT Inc. (GMRE). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus LTC's +26. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — STRW or SBRA or CTRE or LTC or GMRE?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.
(SBRA) is the lower-risk stock at -0. 06β versus Strawberry Fields REIT LLC's 0. 69β — meaning STRW is approximately -1167% more volatile than SBRA relative to the S&P 500. On balance sheet safety, CareTrust REIT, Inc. (CTRE) carries a lower debt/equity ratio of 22% versus 8% for Strawberry Fields REIT LLC — giving it more financial flexibility in a downturn.
05Which is growing faster — STRW or SBRA or CTRE or LTC or GMRE?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — STRW or SBRA or CTRE or LTC or GMRE?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus 3. 5% for Strawberry Fields REIT LLC — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus 23. 6% for GMRE. At the gross margin level — before operating expenses — STRW leads at 87. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is STRW or SBRA or CTRE or LTC or GMRE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CareTrust REIT, Inc. (CTRE) is the more undervalued stock at a PEG of 1. 25x versus LTC Properties, Inc. 's 24. 47x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Strawberry Fields REIT LLC (STRW) trades at 19. 4x forward P/E versus 595. 7x for Global Medical REIT Inc. — 576. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STRW: 18. 4% to $15. 33.
08Which pays a better dividend — STRW or SBRA or CTRE or LTC or GMRE?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 3. 2% for CareTrust REIT, Inc. (CTRE).
09Is STRW or SBRA or CTRE or LTC or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc.
(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +50. 9%, STRW: +47. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between STRW and SBRA and CTRE and LTC and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: STRW is a small-cap high-growth stock; SBRA is a small-cap income-oriented stock; CTRE is a small-cap high-growth stock; LTC is a small-cap high-growth stock; GMRE is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.